RxDoctor Payments Data

Jinal Mehta, DPM

Foot & Ankle Surgery · Frisco, TXNPI 1356686539

Payments from drug & device makers

$1,147in general payments, 2019–2025

Across 29 payments — averaging $39.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$360
  • Treace Medical Concepts, Inc.$322
  • Abbott$107
  • Melinta Therapeutics, LLC$103
  • Cardiovascular Systems Inc.$78
  • Zyla Life Sciences, Inc.$39
  • plus $138 from 7 others

What the payments were for

  • Food & beverage$1,147100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)7$360
Treace Medical Concepts, Inc.8$322
Abbott1$107
Melinta Therapeutics, LLC1$103
Cardiovascular Systems Inc.1$78
Zyla Life Sciences, Inc.3$39
Orthofix Medical, Inc.2$32
Smith+Nephew1$31
Stryker1$22
Amgen1$15
KCI USA, Inc.1$14
Novum Pharma, LLC1$12
Tactile Systems Technology Inc1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,147 in reported general payments places this provider in the 20th percentile of 684 foot & ankle surgery providers in Texas.

See all foot & ankle surgery providers in Texas

Medicare billing

Part B allowed, 2024
$43,456
Medicare patients
154
Services billed
628

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methylprednisolone19$112
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav13$91

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Frisco

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →